Gretchen Enright joined the company in 2012 and serves as the Chief Compliance Officer where she provides regulatory oversight of the Compliance & HIPAA Privacy Programs, and Quality Assurance programs. During her time with the company, Gretchen has led the company’s laboratory licensure and inspection programs as well as the quality improvement across all clinical germline and somatic testing systems and pharmaceutical engagements along with the oversight of the corporate compliance program. She also serves as the HIPAA Privacy Officer.
Gretchen Enright received her undergraduate degree in Biology and Chemistry at Moravian College in Bethlehem, PA, completed medical technology training and received her Master’s degree in Business Administration from Webster University in Irvine, CA. Gretchen is licensed by ASCP and CA state in Molecular Biology and has 20+ years of experience in clinical laboratory testing and regulatory oversight. Prior to joining Ambry, she worked at Clarient Diagnostics, Inc. a GE Healthcare company where she held Director of Compliance, regulatory affairs and QA roles. Gretchen initially received her training on the CAS 200 for quantifying DNA in tumor cells at Sacred Heart Hospital in Allentown, PA during her medical technology training, after which she transferred this technology to Nichols Institute (now Quest Diagnostics). She further evolved from immunohistochemistry techniques to molecular pathology and DNA/RNA analysis. Her hobbies include surfing, stand up paddle boarding, sailing, and quality time with her family, friends, and dogs.